145 related articles for article (PubMed ID: 28119224)
1. Clinical significance of isolated del(7p) in myeloid neoplasms.
Gur HD; Wang SA; Tang Z; Hu S; Li S; Medeiros LJ; Tang G
Leuk Res; 2017 Apr; 55():18-22. PubMed ID: 28119224
[TBL] [Abstract][Full Text] [Related]
2. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV
Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442
[TBL] [Abstract][Full Text] [Related]
3. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications.
Hussain FT; Nguyen EP; Raza S; Knudson R; Pardanani A; Hanson CA; Van Dyke D; Tefferi A
Am J Hematol; 2012 Jul; 87(7):684-6. PubMed ID: 22565657
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
[TBL] [Abstract][Full Text] [Related]
5. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
6. AML with myelodysplasia-related changes masquerades as acute panmyelosis with myelofibrosis.
Xu Z
Blood; 2017 Oct; 130(15):1775. PubMed ID: 29025719
[No Abstract] [Full Text] [Related]
7. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
El-Menoufy MAM; Mourad ZI; Farahat NM
J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
[TBL] [Abstract][Full Text] [Related]
8. A sole del(15q) anomaly in post-myelodysplasia acute myeloid leukemia.
Yahata N; Ohyashiki K; Iwase O; Kimura Y; Kodama A; Fukutake K; Toyama K
Leuk Res; 1998 Sep; 22(9):845-7. PubMed ID: 9716017
[TBL] [Abstract][Full Text] [Related]
9. Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.
Patnaik MM; Lasho TL; Finke CM; Knudson RA; Ketterling RP; Chen D; Hoyer JD; Hanson CA; Tefferi A
Am J Hematol; 2011 May; 86(5):393-8. PubMed ID: 21523797
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.
Kim YG; Cho SY; Park TS; Oh SH; Yoon HJ
Ann Clin Lab Sci; 2011; 41(1):79-83. PubMed ID: 21325260
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic Features of Myeloid Neoplasms Associated with Chromosome 7 Abnormalities.
Chen X; Wood BL; Cherian S
Cytometry B Clin Cytom; 2019 Jul; 96(4):300-309. PubMed ID: 30806023
[TBL] [Abstract][Full Text] [Related]
12. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
Estey E; Trujillo JM; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich EJ; Stass S
Hematol Pathol; 1992; 6(1):43-8. PubMed ID: 1601822
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Stephenson J; Czepulkowski B; Hirst W; Mufti GJ
Leuk Res; 1996 Mar; 20(3):235-41. PubMed ID: 8637218
[TBL] [Abstract][Full Text] [Related]
14. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia with translocation (1;21).
Hamza A; Khan U; Khawar S; Snower D
Mol Biol Rep; 2018 Jun; 45(3):347-351. PubMed ID: 29569103
[TBL] [Abstract][Full Text] [Related]
16. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
[TBL] [Abstract][Full Text] [Related]
17. Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.
Blatt K; Herrmann H; Hoermann G; Willmann M; Cerny-Reiterer S; Sadovnik I; Herndlhofer S; Streubel B; Rabitsch W; Sperr WR; Mayerhofer M; Rülicke T; Valent P
Clin Cancer Res; 2014 Jul; 20(13):3589-602. PubMed ID: 24799522
[TBL] [Abstract][Full Text] [Related]
18. Deletions of chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker chromosome confirmed by array comparative genomic hybridization.
Woo KS; Kim KE; Kim KH; Kim SH; Park JI; Shaffer LG; Han JY
Cancer Genet Cytogenet; 2009 Oct; 194(2):71-4. PubMed ID: 19781438
[TBL] [Abstract][Full Text] [Related]
19. Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasms.
Goswami RS; Wang SA; DiNardo C; Tang Z; Li Y; Zuo W; Hu S; Li S; Medeiros LJ; Tang G
Mod Pathol; 2016 Jul; 29(7):727-34. PubMed ID: 27056073
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
